Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5087131
Max Phase: Preclinical
Molecular Formula: C34H42N4O2
Molecular Weight: 538.74
Molecule Type: Unknown
Associated Items:
ID: ALA5087131
Max Phase: Preclinical
Molecular Formula: C34H42N4O2
Molecular Weight: 538.74
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NCc1ccc(-c2ccccc2)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC(C)(C)C
Standard InChI: InChI=1S/C34H42N4O2/c1-23(2)19-30(35-21-24-15-17-26(18-16-24)25-11-7-6-8-12-25)32(39)37-31(33(40)38-34(3,4)5)20-27-22-36-29-14-10-9-13-28(27)29/h6-18,22-23,30-31,35-36H,19-21H2,1-5H3,(H,37,39)(H,38,40)/t30-,31-/m0/s1
Standard InChI Key: HMMDUVIIRCASEM-CONSDPRKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 538.74 | Molecular Weight (Monoisotopic): 538.3308 | AlogP: 5.98 | #Rotatable Bonds: 11 |
Polar Surface Area: 86.02 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.87 | CX Basic pKa: 7.93 | CX LogP: 6.17 | CX LogD: 5.53 |
Aromatic Rings: 4 | Heavy Atoms: 40 | QED Weighted: 0.19 | Np Likeness Score: -0.43 |
1. Di Sarno V, Lauro G, Musella S, Ciaglia T, Vestuto V, Sala M, Scala MC, Smaldone G, Di Matteo F, Novi S, Tecce MF, Moltedo O, Bifulco G, Campiglia P, Gomez-Monterrey IM, Snoeck R, Andrei G, Ostacolo C, Bertamino A.. (2021) Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization., 226 [PMID:34571172] [10.1016/j.ejmech.2021.113863] |
Source(1):